ANET Electrosurgery Applicator Pilot Evaluation Study

Official Title

ANET Electrosurgery Applicator Pilot Evaluation Study


Evaluate the preliminary safety and performance of the Electrosurgery Applicator (ANET device) during and after bronchoscopic ablation of a target pulmonary nodule/tumour.

Trial Description

Primary Outcome:

  • ANET related peri-procedural Adverse Events
This study is a prospective, single arm, single centre study that will evaluate the effectiveness of the ANET Electrosurgery Applicator in up to 10 subjects. Subjects who consent to participate in this study will have a lung tumour that is scheduled to be removed surgically as part of their normal treatment. During the surgical procedure, just prior to resection the subject's tumour will be treated with the ANET device. The ANET device uses a bronchoscope to reach the tumour. Ultrasound on the bronchoscope, CT, and X-rays are used to make sure the ANET device is in the tumour. Once in the tumour, the ANET device uses radio-frequency (RF) ablation to treat the tumour. After standard surgical resection the tumour and surrounding tissue is evaluated to characterize the effect of the ANET.

View this trial on

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society